Answers are grounded in this paper and cite their sources.
Tumor cells that survive radiation are more sensitive to T-cell-mediated lysis due to a spectrum of biological adaptations to cellular stress (defined as immunogenic modulation), including enhanced antigen processing and cell-surface presence of calreticulin. This mechanism can be exploited to maximize clinical benefit in patients receiving radiotherapy plus immunotherapy.
No takes yet. Share an insight, caveat, or question.
Gameiro et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: